CSL Behring Aktiebolag
Global biotechnology leader developing innovative therapies for rare and serious diseases.
Oversikt
- 20–49
- Ansatte
- 1–5mrd SEK
- Omsetning
- 1996
- Grunnlagt
Nøkkelbeslutningstakere
Gordon Naylor
Chief Executive Officer and Managing Director, CSL
Izumi Yoshida
Representative Director and President
Helena Bragd
General Manager, CSL Behring Nordics
Beskrivelse
CSL Behring is a global leader in biotechnology, dedicated to discovering, developing, and delivering innovative therapies for over a century. The company is driven by a core promise to save and improve the lives of people suffering from rare and serious diseases. Their primary focus areas include h...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Partihandel med medicinsk utrustning och apoteksvaror
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556530197401
Beslutningstakere
3 kontakter i FunnelfeedrGordon Naylor
Chief Executive Officer and Managing Director, CSL
Izumi Yoshida
Representative Director and President
Helena Bragd
General Manager, CSL Behring Nordics
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Swedish Orphan Biovitrum AB (publ)
200–499 ansatteGlobal biopharma unlocking breakthrough therapies for rare diseases.
Vifor Pharma Nordiska AB
20–49 ansatteGlobal leader developing innovative therapies for iron deficiency and kidney disease.
OCTAPHARMA NORDIC AB
5–9 ansatteDeveloping and manufacturing life-saving plasma-derived therapies globally.
AMICUS THERAPEUTICS LTD
1–4 ansatteGlobal biotechnology company developing transformative medicines for rare diseases.
VIFOR PHARMA NORDISKA AB
Global leader developing innovative therapies for iron deficiency and kidney disease.
Utforsk mer
Spørsmål om CSL Behring Aktiebolag
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo